Bogoyavlenskiy, A., et al. Nanoparticle Engineering in Modern Vaccinology: From Delivery Platforms to Immune-Programming Architectures. Molecules, 2026 Jul 17, 31(14):2501. PMID: 42513179

This paper provides a comprehensive overview of advanced nanoparticle-based vaccine platforms, including a focused emphasis on saponin-derived self-assembling nanoplatforms such as ISCOMs and Matrix-M. It highlights how these natural amphiphilic saponins intrinsically possess both delivery and immunostimulatory functions, effectively acting as adjuvants that promote robust humoral and cellular immune responses, including cross-presentation and mucosal immunity. 

The review underscores recent advances in understanding saponin self-assembly, structure-activity relationships, and their translation into clinically approved adjuvants, positioning them as versatile tools for next-generation vaccines. Its uniqueness lies in synthesizing insights from structural biology, immunology, and nanotechnology to demonstrate how naturally derived saponins can be engineered into sophisticated nanoplatforms capable of precise immune programming. 

Given the ongoing need for safe, potent adjuvants, especially highlighted by COVID-19 vaccine developments, this paper is important for its detailed exploration of how saponins are transforming immunoengineering, bridging natural product chemistry with cutting-edge nanotechnology to enhance vaccine efficacy and open new avenues in personalized and mucosal vaccination.

Click here to access the full scientific paper.